Log in to save to my catalogue

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with c...

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A681632134

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

About this item

Full title

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Publisher

BioMed Central Ltd

Journal title

Molecular Cancer, 2021, Vol.20 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A681632134

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A681632134

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-021-01437-0

How to access this item